Calciseptine
Alternative Names: CalciseptinLatest Information Update: 31 Oct 2003
At a glance
- Originator Peptide Institute
- Class Antihypertensives; Cardiotonics
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 31 Oct 2003 Discontinued for Hypertension in Japan (unspecified route)
- 26 Apr 1995 No-Development-Reported for Hypertension in Japan (Unknown route)